Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

Fig. 2

Incidence rate reduction of all TB by 50% efficacy, 10-year duration of protection pre- and post-infection efficacy (P&PI) and post-infection efficacy (PSI) vaccines in India (top) and China (bottom). Lines represent median model incidence rate; ribbons represent model uncertainty. Vaccine is introduced in 2027. Note: y-axis scales on subplots differ

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us